Rein Therapeutics Inc. (RNTX) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Rein Therapeutics Inc.

    NASDAQ: RNTX · Real-Time Price · USD
    1.19
    0.03 (2.59%)
    At close: Oct 03, 2025, 3:59 PM
    1.19
    0.00%
    After-hours: Oct 03, 2025, 06:21 PM EDT

    Rein Therapeutics Cash Flow Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Net Income
    		 -62.88M -15.73M -27.33M -26.16M
    Depreciation & Amortization
    		 63K 119K 169K 121K
    Stock-Based Compensation
    		 1.12M 1.19M 2.08M 2.26M
    Other Working Capital
    		 2.69M -399K -90K 628K
    Other Non-Cash Items
    		 37M -4K -208K -213K
    Deferred Income Tax
    		 n/a n/a n/a n/a
    Change in Working Capital
    		 2.41M -5.38M 420K 242K
    Operating Cash Flow
    		 -22.29M -19.81M -24.86M -23.75M
    Capital Expenditures
    		 n/a n/a n/a -157K
    Cash Acquisitions
    		 n/a -96K n/a n/a
    Purchase of Investments
    		 n/a n/a -21.85M -73.58M
    Sales Maturities Of Investments
    		 n/a 16.25M 48.31M 37.75M
    Other Investing Acitivies
    		 n/a 42K n/a 66K
    Investing Cash Flow
    		 n/a 16.2M 26.46M -35.92M
    Debt Repayment
    		 n/a n/a n/a n/a
    Common Stock Repurchased
    		 n/a n/a n/a n/a
    Dividend Paid
    		 n/a n/a n/a n/a
    Other Financial Acitivies
    		 7.17M 15.79M n/a 74K
    Financial Cash Flow
    		 17.82M 15.79M n/a 55.66M
    Net Cash Flow
    		 -4.47M 12.12M 1.59M -4.01M
    Free Cash Flow
    		 -22.29M -19.81M -24.86M -23.91M

    Add to Watchlist